Literature DB >> 27330271

The association of sleep quality with dry eye disease: the Osaka study.

Motoko Kawashima1, Miki Uchino2, Norihiko Yokoi3, Yuichi Uchino2, Murat Dogru1, Aoi Komuro3, Yukiko Sonomura3, Hiroaki Kato3, Shigeru Kinoshita3, Kazuo Tsubota1.   

Abstract

PURPOSE: To investigate the association of dry eye disease with sleep quality.
METHODS: In 2011, a cross-sectional survey was conducted among all the employees, mainly young and middle-aged Japanese office workers, who used visual display technology, at a company in Osaka, Japan (N=672; age range =26-64 years). The participants were classified according to the Japanese dry eye diagnosis criteria by dry eye examination results including the Schirmer test, fluorescein and lissamine green staining, tear film break-up time, and symptom questionnaire into three groups as follows: definite dry eye disease, probable dry eye disease, and no dry eye disease. To determine sleep quality, Japanese version of the Pittsburgh Sleep Quality Index (global score) was implemented. The global score (range =0-21) was calculated by summing seven sleep variable scores (scale, 0-3); scores ≥5.5 indicated poor sleep.
RESULTS: The total mean global score was 5.1±2.3 (completed N=383); 45% of the dry eye disease participants reported having poor sleep quality, while 34% of the no dry eye disease participants did so, with a significant difference found in the global score (P=0.002). Furthermore, a statistically significant association was observed between the global score and dry eye disease (P=0.005).
CONCLUSION: Poor sleep quality is associated with dry eye disease, especially with dry eye symptoms.

Entities:  

Keywords:  Pittsburgh Sleep Quality Index; dry eye; questionnaire; sleep quality; symptom; tear film break-up time; visual display terminals

Year:  2016        PMID: 27330271      PMCID: PMC4898440          DOI: 10.2147/OPTH.S99620

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Dry eye disease (DED) is widely recognized as a multifactorial chronic disease that is highly prevalent in many countries, including Japan. DED has recently gained recognition as a public health problem.1,2 DED presents with various symptoms that significantly affect the quality of life and work ability, as well as the physical, social, and psychological well-being of an individual, by causing impaired visual function, psychological problems, or both.3–9 Ocular symptoms such as dryness, eyestrains, and blurry vision are commonly reported symptoms related to visual display terminal (VDT) users.10 VDT exposure has been increasing among office workers because of the rapid advancement of information technology. A recent large-scale epidemiologic study of office workers in Japan concluded that VDT work is considered one of the key risk factors for DED.11–13 These studies illustrate how significantly DED can impact a patient’s functioning in the modern technological society. On the other hand, sleep is essential to our physical and mental well-being, and the number of people with a sleep deficiency seems likely to increase. Sleep deficiencies are considered a public health problem.14,15 Furthermore, mental health maintenance has been increasingly recognized as critical with respect to the management of office workers, and several studies have shown that sleep quality is associated with the mental health of office workers.16 Recent studies also suggest that a sleep disturbance is associated with circadian rhythm disruption and even hypertension (HT) and metabolic syndrome.17–20 It has been reported that tear secretion and tear stability have a circadian rhythm.21,22 A study also suggested that the tear secretion system might be associated with the renin–angiotensin system,23 as metabolic syndrome patients have lower tear secretion.24 Accordingly, we speculate that sleep quality is associated with DED. We conducted the present study to clarify the relation between poor sleep quality and DED. Thus, the aim of this study was to investigate the relationship between sleep quality and DED among VDT workers.

Materials and methods

In 2011, we conducted a cross-sectional survey of all the employees, mainly consisting of young and middle-aged Japanese office workers, who used VDT at a company in Osaka, Japan (N=672; age range =26–64 years). The detailed study protocols have been shown in previous reports, and the methods and grading scale used in this study have been previously published.13 All ophthalmic examinations were performed by seven ophthalmologists who were DED specialists. In order to unify assessment of objective evaluation, the DED specialists reconfirmed the DED scoring system before examination. We investigated the association of DED parameters (the Schirmer test-I values, tear film break-up time [BUT] test values, corneal and conjunctival staining scores, and symptoms) with physical activity level and sleep quality. Written informed consent was obtained from all participants. Candidates with a history of refractive surgery were excluded from the study. Contact lens wearers and those with meibomian gland dysfunction were included in this study. We defined the duration of VDT use (stratified, none to over 10 hours in 1-hour categories) including both office and beyond office hours and contact lens use (yes or no). Past/current history of certain common systemic diseases such as HT, diabetes mellitus, depression, and use of systemic medications was determined by asking the participants whether they had ever been told by their physicians that they had these conditions, or they had used any systemic medications, including antidepressants. The research followed the tenets of the Declaration of Helsinki, and this study design was approved by the Institutional Review Board of Ryogoku Eye Clinic in Tokyo, Japan.

Diagnosis of DED

On the basis of the dry eye examination results including the Schirmer test, fluorescein and lissamine green staining, BUT, and the symptom questionnaire, the participants were classified into the following three groups: definite DED, probable DED, and non-DED. A dry eye diagnosis was made according to the latest Japanese dry eye diagnostic criteria (2006) as follows: 1) presence of dry eye symptomatology; 2) presence of qualitative or quantitative disturbance of the tear film (Schirmer test ≤5 mm or BUT ≤5 seconds); and 3) presence of keratoconjunctival epithelial damage (total score of fluorescein and lissamine green staining ≥3 points). A diagnosis of definite DED required adherence to all the three criteria. Subjects fulfilling two of the three criteria were diagnosed with probable DED, and those fulfilling one or none of the three criteria were given the diagnosis of non-DED.13,25,26

Ocular surface symptom questionnaire

We used a 29-item questionnaire to evaluate the symptoms associated with dry eyes (Table S1).26,27 The questionnaire consisted of three categories: 12 questions on dry eye symptoms, nine on visual symptoms, and eight on environmental factors. Each question was answered with a frequency graded on a 5-point severity scale: 0, always; 1, often; 2, sometimes; 3, rarely; and 4, never. The total symptom score was calculated using the following formula: questionnaire score = (sum of the scores from all the answered questions ×100)/(total number of questions answered ×4). The validity and reliability of this questionnaire had been confirmed.26,27

Sleep quality

A Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J)28 was used to measure the patients’ recent sleep quality and sleep quantity. PSQI is an effective and useful instrument for measuring subjective sleep quality and sleep disturbances.29 The PSQI consists of 17 items, generated from seven components, including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, sleep medication usage, and daytime dysfunction. The score for each component ranged from 0 to 3. The sum of the scores of these seven components provided a global PSQI score that ranged from 0 to 21. Generally, higher scores indicate poorer sleep.28,29 In PSQI-J, a cutoff score of >5.5 has a sensitivity of 80.0%–85.7% for various patient groups and a specificity of 86.6% for control subjects.30

Statistical analysis

Categorical variables were analyzed using the χ2 test, and continuous variables using Student’s t-test. After adjusting for any possible confounders (sex, age, and VDT hours), analysis of variance was used to estimate the impact of DED on the PSQI score. Additional adjustment for HT and diabetes mellitus (which was not associated with PSQI score, data not shown) did not affect the findings and was not included in the final models. P-values <0.05 were considered significant. All statistical analyses were performed using Statistical Analysis Software, Version 9.2 (SAS Institute Inc., Cary, NC, USA).

Results

The survey response rate for completing the PSQI, the dry eye questionnaires, and the dry eye examinations was 57.0% (383/672). We did not observe any subjects who had been diagnosed with depression and anxiety in the present study. The respondents’ characteristics are summarized in Table 1. In comparison with the non-DED group, there were more females in the DED group. Subjects in the DED group showed longer VDT use than those in non-DED group.
Table 1

Characteristics of the study respondents who completed the dry eye disease examination and the Japanese version of the Pittsburgh Sleep Quality Index questionnaire

DED (definite + probable) group
Non-DEDTotalP-value (DED vs non-DED)
DefiniteProbableSubtotal
Total
 n43206249134383
Sex
 Men, n (%)21 (48.8)128 (62.1)149 (59.8)103 (76.9)252 (65.8)0.001*
 Women, n (%)22 (51.2)78 (37.9)100 (40.2)31 (23.1)131 (34.2)
Age
 Mean ± SD40.8±7.142.7±8.342.4±8.142.7±9.042.5±8.40.716**
Age (category)
 20s, n (%)3 (7.0)9 (4.4)12 (4.8)13 (9.7)25 (6.5)0.050*
 30s, n (%)16 (37.2)65 (31.6)81 (32.5)31 (23.1)112 (29.2)
 40s, n (%)18 (41.9)90 (43.7)108 (43.4)55 (41.0)163 (42.6)
 50s, n (%)6 (14.0)42 (20.4)48 (19.3)35 (26.1)83 (21.7)
VDT time
Mean ± SD8.4±2.18.1±2.38.1±2.37.6±2.18.0±2.20.020**
VDT time (two categories)
<8 h, n (%)31 (72.1)146 (70.9)177 (71.1)113 (84.3)290 (75.7)0.006*
≥8 h, n (%)12 (27.9)60 (29.1)72 (28.9)21 (15.7)93 (24.3)

Notes:

χ2 test;

Student’s t-test.

Abbreviations: DED, dry eye disease; SD, standard deviation; VDT, visual display terminal; h, hours.

A comparison of the sleep quality between DED and non-DED groups is shown in Table 2. The total mean PSQI global score was 5.1±2.3. In the DED group, 45% of the participants reported poor sleep quality, while 34% of those in the non-DED group reported the same, with a significant difference found in the global score between the DED (5.4±2.2) and the non-DED groups (4.6±2.3; Student’s t-test, P=0.002) (Table 2).
Table 2

Sleep quality and dry eye disease

DED (definite + probable)Non-DEDTotalP-value
Sleep quality (PSQI-J)
Score
 Mean ± SD5.4±2.24.6±2.35.1±2.30.002*
Category
 Normal, n (%)137 (55.0)89 (66.4)2260.040**
 Abnormal, n (%)112 (45.0)45 (33.6)157

Notes:

Student’s t-test;

χ2 test.

Abbreviations: DED, dry eye disease; PSQI-J, Japanese version of the Pittsburgh Sleep Quality Index; SD, standard deviation.

Next, we investigated the association between the DED parameters and the PSQI score. The abnormal Schirmer value group had a significantly higher rate of abnormal sleep quality than that of normal Schirmer value group (P=0.021) (Table 3). No significant differences were observed between the groups in PSQI scores, BUT, and ocular surface staining score. The dry eye symptom score was significantly higher in the abnormal sleep quality group (28.2±15.3) than that in the normal sleep quality group (22.1±12.2, P<0.001) (Figure 1).
Table 3

The Japanese version of the Pittsburgh Sleep Quality Index questionnaire score and dry eye objective parameters

nPSQI-J score
<5.5 (normal) 226≥5.5 (abnormal) 157Total 383P-value (χ2 test)
Schirmer value≤5 mm (abnormal), n (%)29 (45.3)640.021
>5 mm (normal), n (%)197 (61.8)122 (38.2)319
BUT≤5 s (abnormal), n (%)173 (58.2)2970.662
>5 s (normal), n (%)53 (61.6)33 (38.4)86
Ocular surface staining score<3 (normal), n (%)187 (58.6)132 (41.4)3190.838
≥3 (abnormal), n (%)39 (60.9)64

Abbreviations: BUT, tear film break-up time; PSQI-J, Japanese version of the Pittsburgh Sleep Quality Index; s, seconds.

Figure 1

The association between sleep quality and dry eye symptom.

Note: P-value was calculated with Student’s t-test.

Abbreviation: PSQI-J, Japanese version of the Pittsburgh Sleep Quality Index.

Furthermore, a significant association between the DED and the PSQI score (P=0.005) (Table 4) was found while analyzing models to evaluate the association between the PSQI score and the DED, after considering the possible influence of other factors known to be associated with DED (age, sex, and VDT hours).
Table 4

Dry eye disease associated with the Japanese version of the Pittsburgh Sleep Quality Index questionnaire score and adjusted for other factors

SourcedfSSMSFP-value
Dry eye140.02740.0277.960.005
Sex12.7002.7000.540.464
Age (four categories)329.5499.8501.960.120
VDT working hours (two categories)13.6513.6510.730.395
Error3761,891.2475.030
Total3821,975.473

Note: Adjusted for sex, age, and VDT working hours for each group.

Abbreviations: df, degrees of freedom; F, F-value; MS, mean square; SS, sum of squares; VDT, visual display terminal.

Discussion

In this cross-sectional study, we found that sleep quality was associated with DED among the office workers, and 45% of the participants in the DED group reported poor sleep quality. The results of our study suggested that sleep disturbances seem to be an influencing factor of DED, especially with dry eye symptoms (Figure 1). PSQI-J score was significantly associated with DED (P=0.005). This study revealed that all patients with definitive DED had chronic discomfort present in eyes during wake and sleep. Previous studies reported that a sleep disturbance because of sleep apnea syndrome, which is characterized by recurrent complete or partial upper airway obstructions during sleep, was associated with DED.31–33 Sjögren’s syndrome is often complicated with severe DED, and Sjögren’s syndrome patients tend to have sleep disturbances. It is considered to be related to the increased surface tension forces of the salivary and upper airway lining that are involved in the pathophysiology of obstructive sleep apnea.34–37 However, no significant correlations were found among the measures of sleep disruption, sleep apnea severity, and subjective sleep quality.37 The results obtained show that it is important to consider other possible explanations such as psychological factors because several studies have reported discrepancies between the subjective and objective evaluations of sleep37,38 (eg, the positive and negative affective states that are linked with physical health outcomes, as substantial evidence exists regarding the association of negative affective states with both sleep duration and quality).39–41 In this study, sleep disturbances were significantly associated with dry eye symptoms. One caveat of this study was that it utilized the PSQI, a self-reported questionnaire, to evaluate sleep quality. However, in this study, we revealed not only the dry eye symptoms, but also the diagnosis of DED. In addition, a low Schirmer value was significantly associated with sleep disturbance (Table 3). Consistent with this study results, poor sleep quality has been recently reported to be one of the risk factors for DED.42 In the People’s Republic of China, a cross-sectional survey conducted among senior high school students demonstrated a significant association between sleep quality and DED.42 Meanwhile, mental health problems among office workers have been also increasingly acknowledged as a severe social problem, and sleep quality is considered to be involved in impairing mental health,16 as its association with sleep quality may be related to DED symptoms. For instance, depression, one of the major mental health conditions, is known to be associated with sleep disturbance,43 although no subjects reported having been diagnosed with depression or using antidepressants in the present study. Interestingly, depression has been reported to be associated with DED symptoms in people with normal or mildly reduced tear production.44 A study of the US Veterans Affairs population demonstrated that depression increases the risk of DED.33 Furthermore, the use of VDT including laptop computers, tablets, electronic readers, and smartphones is considered one of the strong risk factors of DED; in fact, it is well known that VDT use can induce various psychological and physiological adverse effects including various symptoms of DED. Consequently, DED is more prevalent in office workers who tend to have a high exposure to VDT,11 and has been reported to lead to the deterioration of work performance,9 which should be one of the crucial issues in business management. In addition, the use of electric lights at night, such as VDT use, leads to disrupted sleep for an increasing number of people.15 The daytime office environment also has an effect on sleep and may lead to sleep disturbance.45 In other words, less use of VDT may improve the symptoms of DED and sleep quality because less VDT exposure time reduces the risk of DED.11,12 These findings, however, should be viewed in light of several study limitations. Selection bias is one of the major limitations that should be considered because of the low response rate (57.0%). We used a self-reported questionnaire to investigate sleep quality; therefore, future research should be conducted implementing objective tools to evaluate sleep quality. Also, we would like to investigate subtypes of sleep disturbance and DED. In this study, we had no participants with sleep apnea, but such connection among DED, sleep disturbance, and sleep apnea should be investigated. Furthermore, as with all cross-sectional studies, a causal relationship remains unclear. In the future, given the results of this study, we should consider the impact of nighttime and daytime exposures to VDT separately on DEDs and examine those persons who have the same VDT exposure time. Also, the VDT work-related complaints such as headache and shoulder pain, in addition to DED, should be investigated about their effects on sleep as a prospective study.

Conclusion

In conclusion, although larger longitudinal or interventional trials are necessary, we found that sleep quality is associated with DED. A sleep disturbance seems to be an influencing factor on DED, especially on dry eye symptoms. Newly designed Dry Eye Symptom Questionnaire Notes: Of the 29 questions, 1 through 29, except for 21, were classified into the following five stages: 4, always; 3, often; 2, occasionally; 1, rarely; and 0, never. Question 21 was classified into the following five stages: 4, not possible; 3, with difficulty; 2, moderately possible; 1, probable; and 0, not a problem.
Table S1

Newly designed Dry Eye Symptom Questionnaire

Three-part questionnaire
A Symptom frequency and severity scores for dryness
  1) Do you feel dryness in your eyes?
  2) Are your eyes uncomfortable?
  3) Do you experience a foreign body sensation in your eyes?
  4) Do you have any pain in your eyes?
  5) Do you feel any eyestrain?
  6) Do you have any discomfort in your eyes?
  7) Are your eyes bloodshot?
  8) Do you have any itching in your eyes?
  9) Do you have any difficulty opening your eyes?
10) Do you have any irritation in your eyes?
11) Do your eyes feel heavy?
12) If you have any other symptoms, please write it in the parentheses beneath and circle the frequency
Total (1–12): () – A
B Symptom frequency severity scores for visual disturbance
13) Do you have hazy vision?
14) Do you have any glare?
15) While reading, do your dry eye symptoms worsen, and it becomes hard to continue reading?
16) While driving, do your dry eye symptoms worsen, and it becomes difficult to drive?
17) While operating the computer, do your dry eye symptoms worsen, and it becomes difficult to continue?
18) While watching TV or movies, do your dry eye symptoms worsen, and it becomes difficult to watch?
19) Do you have any after-images?
20) Do you think that blinking affects your sight?
21) Can you keep your eyes open without blinking for 10 seconds or more?
Total (13–21): () – B
C Symptom frequency severity scores for environmental and lifestyle factors: Do your dry eye symptoms worsen?
22) When the wind is strong?
23) When it is dry in winter or summer?
24) When the air conditioning is on?
25) While flying?
26) When you feel stressed in daily life?
27) After alcohol consumption?
28) When you smoke or are exposed to someone smoking next to you?
29) When you are wearing contact lenses?
Total (22–29): () – C

Notes: Of the 29 questions, 1 through 29, except for 21, were classified into the following five stages: 4, always; 3, often; 2, occasionally; 1, rarely; and 0, never. Question 21 was classified into the following five stages: 4, not possible; 3, with difficulty; 2, moderately possible; 1, probable; and 0, not a problem.

  43 in total

Review 1.  Shift work and cardiovascular risk factors: new knowledge from the past decade.

Authors:  Yolande Esquirol; Bertrand Perret; Jean Bernard Ruidavets; Jean Claude Marquie; Eloi Dienne; Michel Niezborala; Jean Ferrieres
Journal:  Arch Cardiovasc Dis       Date:  2011-11-21       Impact factor: 2.340

Review 2.  Psychosocial features of depression: a systematic literature review.

Authors:  Maria Cabello; Blanca Mellor-Marsá; Carla Sabariego; Alarcos Cieza; Jerome Bickenbach; Jose Luis Ayuso-Mateos
Journal:  J Affect Disord       Date:  2011-12-31       Impact factor: 4.839

3.  Surface tension of upper airway mucosal lining liquid in obstructive sleep apnea/hypopnea syndrome.

Authors:  Jason P Kirkness; Melanie Madronio; Rosie Stavrinou; John R Wheatley; Terence C Amis
Journal:  Sleep       Date:  2005-04       Impact factor: 5.849

4.  Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypopnea syndrome.

Authors:  Randy A Karger; W Abraham White; Won-Chan Park; A Gabriela Rosales; Jay W McLaren; Eric J Olson; John J Woog
Journal:  Ophthalmology       Date:  2006-07-07       Impact factor: 12.079

Review 5.  [Progress of research on quality of life of dry eye patients].

Authors:  Mei-Yan Li; Lan Gong
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2011-02

6.  The impact of contact lens wear and visual display terminal work on ocular surface and tear functions in office workers.

Authors:  Takashi Kojima; Osama M A Ibrahim; Tais Wakamatsu; Atsushi Tsuyama; Junko Ogawa; Yukihiro Matsumoto; Murat Dogru; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2011-08-25       Impact factor: 5.258

7.  Psychosocial factors and sleep efficiency: discrepancies between subjective and objective evaluations of sleep.

Authors:  Marta Jackowska; Samantha Dockray; Hilde Hendrickx; Andrew Steptoe
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

8.  Impact of dry eye syndrome on vision-related quality of life.

Authors:  Biljana Miljanović; Reza Dana; David A Sullivan; Debra A Schaumberg
Journal:  Am J Ophthalmol       Date:  2007-01-02       Impact factor: 5.258

9.  Effect of reduced illumination on insomnia in office workers.

Authors:  Tomoaki Kozaki; Nobuhiko Miura; Masaya Takahashi; Akira Yasukouchi
Journal:  J Occup Health       Date:  2012-05-18       Impact factor: 2.708

10.  Decreased tear volume in patients with metabolic syndrome: the Osaka study.

Authors:  Motoko Kawashima; Miki Uchino; Norihiko Yokoi; Murat Dogru; Yuichi Uchino; Aoi Komuro; Yukiko Sonomura; Hiroaki Kato; Shigeru Kinoshita; Kazuo Tsubota
Journal:  Br J Ophthalmol       Date:  2013-12-16       Impact factor: 4.638

View more
  20 in total

1.  Function and Morphology of the Meibomian Glands Using a LipiView Interferometer in Rotating Shift Medical Staff.

Authors:  Jing Zhang; Zhengzheng Wu; Liangnan Sun; Xin-Hua Liu
Journal:  J Ophthalmol       Date:  2020-08-17       Impact factor: 1.909

2.  Dry eye disease and psychiatric disorders: A systematic review and meta-analysis.

Authors:  Amy Basilious; Cathy Y Xu; Monali S Malvankar-Mehta
Journal:  Eur J Ophthalmol       Date:  2021-12-22       Impact factor: 1.922

3.  A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.

Authors:  Jun Shimazaki; Den Seika; Masamichi Saga; Kazumi Fukagawa; Miki Sakata; Miki Iwasaki; Takashi Okano
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

4.  Sleep and mood disorders in women with dry eye disease.

Authors:  Masahiko Ayaki; Motoko Kawashima; Kazuno Negishi; Taishiro Kishimoto; Masaru Mimura; Kazuo Tsubota
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

5.  Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease.

Authors:  Klemens Fondi; Piotr A Wozniak; Doreen Schmidl; Ahmed M Bata; Katarzyna J Witkowska; Alina Popa-Cherecheanu; Leopold Schmetterer; Gerhard Garhöfer
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

6.  Investigation of Dry Eye Symptoms in Lecturers by Ocular Surface Disease Index

Authors:  Sümbüle Köksoy Vayısoğlu; Emine Öncü; Özer Dursun; Erdem Dinç
Journal:  Turk J Ophthalmol       Date:  2019-06-27

7.  Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease.

Authors:  Darrell E White; Yang Zhao; Hemalatha Jayapalan; Pattabhi Machiraju; Ramu Periyasamy; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-03-19

Review 8.  Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma.

Authors:  Alejandro Martínez-Águila; Alba Martín-Gil; Carlos Carpena-Torres; Cristina Pastrana; Gonzalo Carracedo
Journal:  Biomolecules       Date:  2021-02-24

9.  Effect of Ultrasonic Moisture Glasses on Dry Eye Signs and Symptoms.

Authors:  Shuhei Onomura; Motoko Kawashima; Naohiko Aketa; Shinichiro Kondo; Kazuo Tsubota
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

10.  Acupuncture for the treatment of dry eye: Protocol for systematic review and meta-analysis.

Authors:  Yongzheng Zhu; Qinyu Zhao; Hongling Jia; Hongxing Zhang; Yongchen Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.